Acme Generics Private Limited — Levothyroxine Exporter Profile
Indian Pharmaceutical Exporter · #6 for Levothyroxine · $3.4M export value · DGFT Verified
Acme Generics Private Limited is the #6 Indian exporter of Levothyroxine with $3.4M in export value and 190 verified shipments. Acme Generics Private Limited holds a 4.4% market share in Levothyroxine exports across 9 countries. The company exports 6 pharmaceutical products worth $7.1M across 5 therapeutic categories.
Acme Generics Private Limited — Levothyroxine Export Profile: Buyers & Destinations
Where Does Acme Generics Private Limited Export Levothyroxine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CHILE | $1.1M | 32 | 38.2% |
| UNITED KINGDOM | $926.4K | 94 | 32.1% |
| DOMINICAN REPUBLIC | $313.6K | 30 | 10.9% |
| DOMINICAN REPULIC | $215.0K | 25 | 7.4% |
| ECUADOR | $174.7K | 16 | 6.0% |
| AUSTRALIA | $87.4K | 5 | 3.0% |
| LEBANON | $39.6K | 1 | 1.4% |
| PERU | $25.5K | 5 | 0.9% |
| YEMEN, DEMOCRATIC | $2.0K | 1 | 0.1% |
| HAITI | $741 | 3 | 0.0% |
Acme Generics Private Limited exports Levothyroxine to 12 countries. The largest destination is CHILE accounting for 38.2% of Acme Generics Private Limited's Levothyroxine shipments, followed by UNITED KINGDOM (32.1%) and DOMINICAN REPUBLIC (10.9%). These destinations reflect Acme Generics Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Levothyroxine from Acme Generics Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ALEMBIC PHARMACEUTICALS SPA | CHILE | $979.8K | 21 |
| CRESCENT PHARMA LIMITED | UNITED KINGDOM | $926.4K | 94 |
| PHARMACEUTICAL TECHNOLOGY | DOMINICAN REPUBLIC | $480.6K | 50 |
| ALEMBIC PHARMACEUTICALS SPA. | CHILE | $125.7K | 11 |
| NORTH LIFE PHARMA ECUADOR NLF C.L | ECUADOR | $102.2K | 10 |
| HEALTHCARE LOGISTICS | AUSTRALIA | $87.4K | 5 |
| NORTH LIFE PHARMA ECUADOR NLF C.L. | ECUADOR | $52.1K | 4 |
| YMCA | LEBANON | $39.6K | 1 |
| PHARAMACEUTICAL TECHNOLOGY | DOMINICAN REPULIC | $25.5K | 4 |
| PHARMACEUTICAL TECHNOLOGY DOMINICAN REPUBLIC TAX ID | DOMINICAN REPUBLIC | $22.5K | 1 |
Acme Generics Private Limited supplies Levothyroxine to 17 buyers globally. The largest buyer is ALEMBIC PHARMACEUTICALS SPA (CHILE), followed by CRESCENT PHARMA LIMITED (UNITED KINGDOM) and PHARMACEUTICAL TECHNOLOGY (DOMINICAN REPUBLIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Levothyroxine Export Value and How Much Does Acme Generics Private Limited Contribute?
India exported $60.1M worth of Levothyroxine through 2,385 shipments from 125 suppliers to 71 countries, serving 235 buyers globally. Acme Generics Private Limited contributes $3.4M to this total, accounting for 4.4% of India's Levothyroxine exports. Acme Generics Private Limited ships Levothyroxine to 12 countries through 17 buyers.
What Is the Average Shipment Value for Acme Generics Private Limited's Levothyroxine Exports?
Acme Generics Private Limited's average Levothyroxine shipment value is $17.8K per consignment, based on 190 shipments totaling $3.4M. The largest destination is CHILE (38.2% of Acme Generics Private Limited's Levothyroxine exports).
How Does Acme Generics Private Limited Compare to Other Indian Levothyroxine Exporters?
Acme Generics Private Limited ranks #6 among 125 Indian Levothyroxine exporters with a 4.4% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($14.7M), MACLEODS PHARMACEUTICALS LTD ($13.9M), STERIL-GENE LIFE SCIENCES PRIVATE LIMITED ($9.4M). Acme Generics Private Limited processed 190 shipments to 9 destination countries.
What Levothyroxine Formulations Does Acme Generics Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LEVOTHYROXINE SODIUM TABLETS USP 100 MCGB.NO.EH24LHD062 TO EH24LHD067 MFG.DT.DEC-2024,EXP.DT.NOV-2027 (PACKING-10X10T) | $50.0K | 1 |
| LEVOTHYROXINE SODIUM TABLETS USP 100 MCGB.NO.EH24LHD069 TO EH24LHD074 MFG.DT.DEC-2024,EXP.DT.NOV-2027 (PACKING-10X10T) | $50.0K | 1 |
| Levothyroxine Sodium Tablets USP 50 mcg,BT. EH24LHF002 to EH24LHF007,MD. 12/24,.ED. 11/27,PCK.5X10T.231600X5x10=11580000 | $50.0K | 1 |
| LEVOTHYROXINE SODIUM TABLETS USP 50MCG [280490 PACK X 5 X 10'T] BATCH NO. EH24LHF008 MFG DT.12/24 EXP DT. 11/27; EH25LHF | $50.0K | 1 |
| PHARMACEUTICAL MEDICINES: LEVOTHYROXINESODIUM 50MCG TABLETS,BATCH NO:EH24LTD008TO EH24LTD016,MFG:MAR 2024,EXP:FEB 2026 | $50.0K | 1 |
| Levothyroxine Sodium Tablets USP 50 mcg,BT. EH25LHF007 to EH25LHF012,MD. 01/25,ED. 12/27,PCK.5X10T.241260X5x10=12063000 | $50.0K | 1 |
| Levothyroxine Sodium Tablets USP 50 mcg,BT#EH25LHF013 to EH25LHF017,MD#Jan-25,ED#Dec-27, PCK.5x10T.201030X5X10=10051500 | $50.0K | 1 |
| Levothyroxine Sodium Tablets USP 100mcg,BT#EH25LHD001 to EH25LHD006,MD.Jan-25,ED#Dec-27,PCK.10x10T 118632X10X10=11863200 | $50.0K | 1 |
| Levothyroxine Sodium Tablets USP 100mcg,BT#EH25LHD010 to EH25LHD013,EH25LHD015 to EH25LHD016,MD.FEB-25,ED#JAN-28,** | $50.0K | 1 |
| Levothyroxine Sodium Tablets USP 50 mcg,BT#EH25LHF024 to EH25LHF029,MD.FEB-25,ED#JAN-28, PACKS:240390X5X10=12019500 | $50.0K | 1 |
Acme Generics Private Limited exports 153 distinct Levothyroxine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LEVOTHYROXINE SODIUM TABLETS USP 100 MCGB.NO.EH24LHD062 TO E with 1 shipments worth $50.0K.
Regulatory Requirements: Exporting Levothyroxine to Key Markets
What Acme Generics Private Limited must comply with to export Levothyroxine to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Acme Generics Private Limited Compare to Nearest Levothyroxine Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | WOCKHARDT LIMITED | $5.2M | 103 | 1 | $50.0K |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $4.9M | 119 | 1 | $41.1K |
| 6 | ACME GENERICS PRIVATE LIMITED ★ | $3.4M | 190 | 9 | $17.8K |
| 7 | MYLAN LABORATORIES LIMITED | $3.1M | 64 | 2 | $48.4K |
| 10 | LUPIN LIMITED | $2.0M | 41 | 1 | $50.0K |
Acme Generics Private Limited ranks #6 among 125 Indian Levothyroxine exporters. Average shipment value of $17.8K compared to the market average of $481.0K. The closest competitors by value are WOCKHARDT LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.
Which Indian Ports Ship Levothyroxine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 257 | 10.8% |
| MUNDRA SEA | 257 | 10.8% |
| DELHI AIR CARGO ACC (INDEL4) | 207 | 8.7% |
| NHAVA SHEVA SEA (INNSA1) | 207 | 8.7% |
| MUNDRA SEA (INMUN1) | 179 | 7.5% |
| SAHAR AIR | 165 | 6.9% |
| DELHI AIR | 120 | 5.0% |
| JNPT/ NHAVA SHEVA SEA | 98 | 4.1% |
Geopolitical & Trade Policy Impact on Acme Generics Private Limited's Levothyroxine Exports
Acme Generics' export operations are currently navigating a complex geopolitical landscape. The recent Israel-Iran tensions have escalated security risks in the Red Sea and Strait of Hormuz, leading to increased shipping costs and extended transit times for Indian exporters. Major carriers have rerouted vessels around the Cape of Good Hope, adding 10–20 days to shipments and raising freight rates by 40–50% on key India–Europe routes. (livemint.com)
Conversely, the U.S. pharmaceutical sector's reshoring initiatives, aimed at reducing dependency on Chinese APIs, present opportunities for Indian manufacturers like Acme. With the U.S. increasing its domestic generic production capacity, Indian firms are exploring partnerships and establishing production facilities stateside, potentially reducing reliance on Chinese imports by 20–30%. (odrindia.in)
Furthermore, the India–European Union Free Trade Agreement, concluded in January 2026, is set to eliminate tariffs on pharmaceuticals, enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to the EU, providing a competitive edge to companies like Acme Generics. (en.wikipedia.org)
Acme Generics Private Limited — Regulatory Compliance & Quality Standards
Acme Generics has demonstrated a strong commitment to regulatory compliance, with its facilities audited and approved by international agencies, including the USFDA, UK-MHRA, EU-GMP, Health Canada, TGA Australia, ANVISA, INVIMA, and WHO Geneva. (acmegenerics.in) This adherence to stringent quality standards enhances the company's credibility and facilitates access to regulated markets.
The evolving global regulatory environment, characterized by initiatives like the EU's Critical Medicines Act, emphasizes the need for diversified and resilient supply chains. Acme's proactive approach to compliance positions it well to navigate these changes and maintain its competitive standing in the international pharmaceutical market.
About Acme Generics Private Limited
Acme Generics Private Limited exports 6 products worth $7.1M. Beyond Levothyroxine, top products include Acetaminophen, Loperamide, Salicylic, Mycophenolate, Acetylsalicylic. View the complete Acme Generics Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Levothyroxine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Levothyroxine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Acme Generics Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 215 individual customs records matching Acme Generics Private Limited exporting Levothyroxine, covering 153 formulations to 12 countries via 17 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 71+ countries, 235+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Levothyroxine Export Data from Acme Generics Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Acme Generics Private Limited's Levothyroxine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Acme Generics Private Limited
Full Company Profile →
6 products · $7.1M total trade · 5 categories
Levothyroxine Stats
Company Overview
Top Products by Acme Generics Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Acme Generics Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Levothyroxine. For current shipment-level data, contact TransData Nexus.